29th Oct 2020 19:02
(Alliance News) - SourceBio International PLC on Thursday said raised GBP35.0 million in its AIM float as the laboratory services and products targets a boost in its Covid-19 test capacity.
SourceBio said placed 21.6 million shares at 162 pence each. Liberum Capital Ltd acted as nomad, broker and sole bookrunner.
Executive Chair Jay LeCoque said: "We are delighted by the strong support we've received from new institutional investors and our existing shareholders. Our IPO on AIM allows us to significantly increase our Covid-19 testing capacity, accelerate earnings growth in our core business and execute on potential M&A opportunities. It's an exciting time for our business and we look forward to executing on our ambitious growth plans and delivering value to our shareholders."
The stock closed at 169.00p in London on Thursday.
By Eric Cunha; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
SBI.L